Navigation Links
Fast Forward, LLC and Provid Pharmaceuticals Announce Expansion of their Partnership for the Development of PV-267, Provid's Unique MS Drug Candidate
Date:11/17/2010

NEW YORK and NORTH BRUNSWICK, N.J., Nov. 17, 2010 /PRNewswire/ -- Provid Pharmaceuticals, Inc, a drug discovery company, and Fast Forward, LLC, the National Multiple Sclerosis Society's subsidiary devoted to bridging the gap between research and drug development, today announced an expansion of their partnership to support Provid's preclinical studies of their candidate MS drug, PV-267.  This novel, highly selective small molecule is designed to block a critical step in the autoimmune process of MS, which leads to the destruction of the body's protective myelin in the central nervous system and to the ultimate accumulation of disability.  

The expanded partnership will enable Provid to enhance knowledge of the immune mechanisms involved in the activity of PV-267, paving the way for future development and clinical studies.  The biological studies will be carried out by Dr. Thomas Forsthuber, Provid's collaborator and a leading immunologist at the University of Texas San Antonio.  

"The partnership between Fast Forward and Provid was begun in May 2009 and helped fund important research," noted Dr. Gary Olson, Provid's President and CEO.  "In these studies, PV-267 was shown to be active in an animal model of MS in transgenic mice that carry the human gene for HLA-DR2, a disease-associated molecule that is involved in the attack of the immune system on myelin, the insulating protein on nerves that are damaged in MS."  Dr. Olson added, "DR2 is present in about 60% of the MS population and PV-267 was designed to be a potent and selective blocker of DR2.  This specificity suggests that PV-267 could have a better safety profile compared with immune-modifying therapies since it will not affect other, normal immune responses."  

The partnership with Provid is one of a series of partnerships between Fast Forward and early stage biotechnology companies. "The results of our
'/>"/>

SOURCE Provid Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA Join Forces to Accelerate Development of Treatments for Multiple Sclerosis and Type 1 Diabetes
2. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
3. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
4. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
5. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
6. Raptor Pharmaceuticals Provides Update of Product Programs
7. Monogram Provides Update on Trofile(TM) Co-Receptor Tropism Assay
8. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
9. Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
10. Most Women With HIV and Their Health Care Providers Have Not Discussed How HIV Might Affect Them Differently Than Men
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN ) ... interview with ABC TV that was broadcast on Saturday September ... the following day on Weekend Breakfast. The interview concerned the ... clinic in Australia for the treatment ... The interview provides certain new information and is being ...
(Date:9/29/2014)... , Sept. 29, 2014  Lpath, Inc. (NASDAQ: ... bioactive lipid-targeted therapeutics, announced today the closing of ... As previously disclosed, Lpath sold 3,605,042 registered shares ... unregistered shares of common stock in a registered ... per share-and-warrant-share combination.  The warrants have an exercise ...
(Date:9/29/2014)... Sept. 29, 2014 Avanir Pharmaceuticals, Inc. (NASDAQ: ... its previously announced public offering of 20,930,000 shares of ... underwriters, full exercise of their option to purchase additional ... per share, before underwriting discounts. J.P. Morgan, Deutsche Bank ... managers for the offering. Piper Jaffray and ...
Breaking Medicine Technology:ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 2ABC TV Interview Discusses the Potential of Trilexium(TM) to Treat Brain Cancer 3Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces Closing of $12.5 Million Registered Direct Offering 3Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 3
... Symmetry Medical Inc. (NYSE: SMA ), a leading ... and other medical markets, announced today that it has entered ... November 3, 2010.  The credit facility includes an "accordion feature" ... million. The credit facility has a term of five years. ...
... Nov. 3, 2010 Aethlon Medical, Inc. (OTC ... in developing therapeutic filtration devices to address infectious ... present tomorrow at the at the Singular Research ... Los Angeles. (Photo:   http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) ...
Cached Medicine Technology:Symmetry Medical Closes $200 Million Credit Facility 2Symmetry Medical Closes $200 Million Credit Facility 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 2Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 3Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference' 4
(Date:9/29/2014)... 2014 NAPW honors ... of Private Pediatrics of Palm Beach as ... recognized for leadership in pediatrics and family care with ... women in the country, spanning virtually every industry and ... a powerfully vibrant networking community with over 600,000 members ...
(Date:9/29/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Top10BestSEOHosting.com has recently compared many Linux ... ) and Bluehost are the most recommended suppliers ...
(Date:9/29/2014)... FL (PRWEB) September 29, 2014 Every ... the school year, cross country running season takes off! ... the fall cross country running season. Zensah®, the leading ... sleeves and compression socks for cross ... cross country runners to reduce delayed onset muscle soreness ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... D.C. September 30, 2014 (PRWEB) September 29, 2014 ... devices like smartphones, tablets and laptops provides the delivery ... all ages, from youth to adult, to raise and ... obtain professional licensure, or to obtain certification in your ... an educated workforce to compete effectively and at MMU ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Dr. Natalie W. Geary, Owner / President of Private Pediatrics of Palm Beach, a 2014 Professional Woman of the Year 2Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Muscle Support and Style With New Compression Leg Sleeves For Cross Country Runners 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 2Health News:MyMobileUniversity invites Corporations, Government Public Agencies, Academia, NGOs’ to Transform Workforce Development by Continued Education, Learning to Impact Lives 3
... Academy of Family Physicians today announced the Consumer Alliance, ... partner, The Coca-Cola Company. , (Logo: ... program that allows corporate partners like The Coca-Cola Company ... the role their products can play in a healthy, ...
... CAMBRIDGE, Mass., Oct. 6 Galenea Corp., a fully-integrated ... been awarded an NIH Challenge Grant in Health and ... and Reinvestment Act of 2009 (Recovery Act). This ... addresses the specific topic of "Screening Approaches to Identify ...
... HOSPITAL ROOM , New research shows that certain noninvasive ... up to a distance of 1 m from patients ... spread of highly contagious respiratory illness within the hospital ... with mild lung injury, researchers from Hong Kong measured ...
... ... to earn continuing education credits , , ... Lincoln, NE (Vocus) October 5, 2009 -- The online ... Solutions (HES) recently received approval from the American Academy of Family Physicians (AAFP). The ...
... Speaker Nancy Pelosi issued the following statement congratulating molecular ... Francisco, who today was named to receive the 2009 Nobel ... W. Greider of Johns Hopkins University School of Medicine and ... of an enzyme that plays a key role in normal ...
... Superhero, to Feature DJ Cut Chemist, Violinist Lili Haydn, The ... Choir, The Raretones and Bells of the Sound , ... Symphony Guild today announced the artist lineup ... annual event which benefits Seattle Children,s Hospital ...
Cached Medicine News:Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 2Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 3Health News:The American Academy of Family Physicians Launches Consumer Alliance With First Partner: The Coca-Cola Company 4Health News:Galenea Awarded RC1 Challenge Grant to Develop Predictive In Vivo Models of Cognition 2Health News:News briefs from the October issue of Chest 2Health News:Health Education Solutions' Advanced Cardiac Life Support Course Gains Approval from American Academy of Family Physicians 2Health News:The Symphony Guild Announces Artist Lineup for 2009 Event 2Health News:The Symphony Guild Announces Artist Lineup for 2009 Event 3
... solution for cataract surgery. A complete ... safe phaco-emulsification procedure. Inadequate visualization of ... in an incomplete capsulorhexis, which carries ... tears and associated complications. Visionblue capsule ...
... a vital dye, used in matured cataract ... fibrous tissue enables the surgeon to see ... preparation of trypan blue combined with sodium ... tolerated following intraocular injection into the anterior ...
Blanket protection against heavier bleeding....
Unmatched versatility for hemostasis wherever needed. Can be applied to suit your needs....
Medicine Products: